While the DNMT3A-regulated epigenetic changes in CAR-T cells induce exhaustion, removing DNMT3A from CAR-T cells improves the anti-tumor activities and avoids possible dysfunction in an IL-10-dependent manner (98). Here, DNMT3A is linked to neoplasm.